Real-world Experience of Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Project: Research

Project Details

Project Description

Collection and Analysis of LaRDR data on Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Short titlePolatuzumab RWD study
StatusFinished
Effective start/end date13/12/2130/04/23

Keywords

  • Lymphoma